Age and Gender Disparities in Evidence-based Treatment for Coronary Artery Disease in the Community: A Cross-sectional Study.
作者信息
Sharma Krishna Kumar, Gupta Rakesh, Basniwal Pawan K, Guptha Soneil, Gupta Rajeev
机构信息
Department of Pharmacology, Lal Bahadur Shastri College of Pharmacy, Jaipur, India.
出版信息
Indian J Community Med. 2011 Apr;36(2):159-60. doi: 10.4103/0970-0218.84138.
Abstract
摘要
相似文献
1
Age and Gender Disparities in Evidence-based Treatment for Coronary Artery Disease in the Community: A Cross-sectional Study.
Indian J Community Med. 2011 Apr;36(2):159-60. doi: 10.4103/0970-0218.84138.
2
Gender disparities in the pharmacological treatment of cardiovascular disease and diabetes mellitus in the very old: an epidemiological, cross-sectional survey.老年人心血管疾病和糖尿病药物治疗中的性别差异：一项流行病学、横断面调查。
Drugs Aging. 2011 Dec 1;28(12):993-1005. doi: 10.2165/11594730-000000000-00000.
3
Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North America.量化疑似冠状动脉疾病有症状患者在药物治疗和生活方式方面的社会人口统计学和收入差异：一项北美横断面研究。
BMJ Open. 2017 Sep 29;7(9):e016364. doi: 10.1136/bmjopen-2017-016364.
4
The use of an anesthesia information system to identify and trend gender disparities in outpatient medical management of patients with coronary artery disease.使用麻醉信息系统识别冠状动脉疾病患者门诊医疗管理中的性别差异并分析其趋势。
Anesth Analg. 2008 Jul;107(1):185-92. doi: 10.1213/01.ane.0000289651.65047.3b.
5
Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations.血管造影“正常”冠状动脉参照节段中的动脉粥样硬化：一项与临床相关的血管内超声研究
J Am Coll Cardiol. 1995 Jun;25(7):1479-85. doi: 10.1016/0735-1097(95)00088-l.
6
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.在血糖异常和冠心病患者中筛查葡萄糖紊乱、心血管风险因素管理和预后的性别差异：来自 ESC-EORP EUROASPIRE 调查的结果。
Cardiovasc Diabetol. 2021 Feb 11;20(1):38. doi: 10.1186/s12933-021-01233-6.
7
Prevalence and variability of internal mammary artery graft use in contemporary multivessel coronary artery bypass graft surgery: analysis of the Society of Thoracic Surgeons National Cardiac Database.当代多支冠状动脉搭桥手术中乳内动脉移植物使用的患病率及变异性：胸外科医师协会国家心脏数据库分析
Circulation. 2009 Sep 15;120(11):935-40. doi: 10.1161/CIRCULATIONAHA.108.832444. Epub 2009 Aug 31.
8
Gender disparities in percutaneous coronary intervention in out-of-hospital cardiac arrest.院外心脏骤停经皮冠状动脉介入治疗中的性别差异。
Am J Emerg Med. 2019 Apr;37(4):632-638. doi: 10.1016/j.ajem.2018.06.068. Epub 2018 Jul 5.
9
Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities.慢性稳定型心绞痛管理的最新进展I：患者处理、诊断、病理生理学、风险分层及性别差异
Vasc Health Risk Manag. 2010 Aug 9;6:635-56. doi: 10.2147/vhrm.s7564.
10
Gender disparities in patient education provided during patient visits with a diagnosis of coronary heart disease.冠心病患者就诊期间所提供的患者教育中的性别差异。
Womens Health (Lond). 2019 Jan-Dec;15:1745506519845591. doi: 10.1177/1745506519845591.
引用本文的文献
1
Abnormal glucose regulation in Chinese patients with coronary artery disease: a gender analysis.中国冠心病患者的葡萄糖调节异常：性别分析。
J Cardiothorac Surg. 2022 May 3;17(1):94. doi: 10.1186/s13019-022-01848-0.
2
Gender differences in 7 years trends in cholesterol lipoproteins and lipids in India: Insights from a hospital database.印度胆固醇脂蛋白和脂质7年趋势中的性别差异：来自医院数据库的见解
Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):211-8. doi: 10.4103/2230-8210.176362.
3
Reverse evidence based medicine.反向循证医学
Pan Afr Med J. 2013 Nov 10;16:89. doi: 10.11604/pamj.2013.16.89.2782. eCollection 2013.
4
Prevention & control of CVD in women & children in India.印度妇女和儿童心血管疾病的预防与控制
Indian J Med Res. 2013 Sep;138(3):281-4.
5
Association between gender, process of care measures, and outcomes in ACS in India: results from the detection and management of coronary heart disease (DEMAT) registry.印度急性冠脉综合征（ACS）中性别、治疗措施流程与结局的相关性：来自冠心病检测和管理（DEMAT）注册研究的结果。
PLoS One. 2013 Apr 24;8(4):e62061. doi: 10.1371/journal.pone.0062061. Print 2013.
本文引用的文献
1
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.基于有效性的女性心血管疾病预防指南——2011年更新版：美国心脏协会指南
Circulation. 2011 Mar 22;123(11):1243-62. doi: 10.1161/CIR.0b013e31820faaf8. Epub 2011 Feb 14.
2
Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.印度初级和二级医疗保健中他汀类药物及其他冠心病二级预防疗法的低使用率。
Vasc Health Risk Manag. 2009;5:1007-14. doi: 10.2147/vhrm.s8017. Epub 2009 Nov 23.
3
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.欧洲动脉粥样硬化调查III：对来自22个欧洲国家的冠心病患者的生活方式、风险因素及心脏保护药物治疗使用情况的调查。
Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):121-37. doi: 10.1097/HJR.0b013e3283294b1d.
4
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.美国心脏协会/美国心脏病学会关于冠心病和其他动脉粥样硬化性血管疾病患者二级预防的指南：2006年更新版：得到美国国立心肺血液研究所认可。
Circulation. 2006 May 16;113(19):2363-72. doi: 10.1161/CIRCULATIONAHA.106.174516.
5
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.动脉粥样硬化血栓形成门诊患者心血管危险因素的国际患病率、识别率及治疗情况
JAMA. 2006 Jan 11;295(2):180-9. doi: 10.1001/jama.295.2.180.
6
Cardiac rehabilitation and secondary prevention of coronary heart disease.冠心病的心脏康复与二级预防
N Engl J Med. 2001 Sep 20;345(12):892-902. doi: 10.1056/NEJMra001529.
7
Age-related differences in management of heart disease: a study of cardiac medication use in an older cohort. Pacemaker Selection in the Elderly (PASE) Investigators.
J Am Geriatr Soc. 1999 Feb;47(2):145-50. doi: 10.1111/j.1532-5415.1999.tb04571.x.
Zotero 插件